Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reproductive Health
Published in: Reproductive Health 1/2012

Open Access 01-12-2012 | Research

Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria

Authors: Olorunfemi E Amoran, Adebayo A Ariba, Christy A Iyaniwura

Published in: Reproductive Health | Issue 1/2012

Login to get access

Abstract

Background

Malaria infection in pregnancy is a major risk factor for maternal and child death, and substantially increases the risk of miscarriage, stillbirth and low birthweight. The aim of this study therefore is to assess the prevalence and determinants of Intermittent preventive treatment of Malaria [IPTp] utilization by pregnant women in a rural town in Western Nigeria.

Methods

This study is an analytical cross-sectional study. All pregnant women that were due for delivery and were attending the three primary health care center in Sagamu town, Nigeria within a 2 months period were recruited into the study. A semi- structured questionnaire was used to collect relevant information.

Results

A total of 255 pregnant women were recruited into the study. The mean age of respondents was 28.07 ± 5.12 years. The mean parity and booking age was 2.7 ± 1.67 and 4.42 ± 1.7 months respectively. The prevalence of Malaria attack in the last 3 months was 122(47.8%). Only 107/255 (40.4%) practice IPTp for malaria prevention during the current pregnancy, with only 14.6% of them taking the second dose during pregnancy as recommended. Chloroquine [27.1%] was the most frequently used medication for the treatment of Malaria in Pregnancy. Early booking age [OR = 1.11, C.I = 0.61–2.01], adverse last pregnancy outcome [OR = 1.23, C.I = 0.36–4.22], and parity [OR = 1.87, C.I = 0.25–16.09] were not statistically significantly associated with IPTp utilization. The only predictor of IPTp use was the knowledge of prophylaxis for malaria prevention [OR = 2.47, C.I = 1.06–3.52] using multivariate analysis.

Conclusion

The study concludes that most women who attend ANC in rural areas in Nigeria do not receive IPTp as expected. A major determinant of utilization of IPTp among the study population was the knowledge of prophylaxis for malaria prevention. This study highlights the importance of health education of the pregnant women in increasing IPTp uptake despite the regular drug stock out at the facility level in rural areas in low resource countries.
Literature
1.
World Health Organization: World Malaria Situation 1993. Weekly Epidemiol Record. 1996, 71: 17-22.
2.
Snow RW: Estimating Mortality, Morbidity and disability due to Malaria among Africa’s non pregnant population. Bull WHO. 1999, 77: 624-640.PubMedPubMedCentral
3.
Steketee R, Nahlen B, Parise M, Menendez C: The Burden of Malaria in Pregnancy in Malaria-Endemic Areas. Am J Trop Med Hyg. 2001, 64: 28-35.PubMed
4.
Sachs J, Malaney P: The economic and social burden of Malaria. Nature. 2002, 415: 23-255. 10.1038/415023a.CrossRef
5.
WHO: WHO World Malaria Report 2010. World Health Organization Global Malaria Programme. 2010, WHO, Geneva
6.
Heggenhougen HK, Hackethal V, Vivek P: The behavioural and social aspects of malaria and its control An introduction and annotated bibliography. 2003, WHO/TDR, Geneva
7.
Shane B: Malaria Continues to Threaten Pregnant Women and Children. Population Reference Bureau Articles. 2001, 2: 15-20.
8.
Meeusen EN, Bischof RJ, Lee CS: Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol. 2001, 46: 169-179. 10.1111/j.8755-8920.2001.460208.x.CrossRefPubMed
9.
Fleming AF: Anaemia in pregnancy. Trans R Soc Trop Med Hyg. 1989, 83: 441-448. 10.1016/0035-9203(89)90241-1.CrossRefPubMed
10.
Morley D, Woodland M, Cuthberson WFJ: Controlled trial of pyremethamine in pregnant women in an African village. BMJ. 1964, 1: 67-68.CrossRef
11.
Falade CO, Yusuf BO, Fadero FF, Mokuolu OA, Hamer DH, Salako LA: Intermittent preventive treatment with sulfadoxine-pyrimethamineis effective in preventing maternal and placental malaria in Ibadan, South West Nigeria. Malar J. 2007, 6: 88-10.1186/1475-2875-6-88.CrossRefPubMedPubMedCentral
12.
World Health Organization: Guidelines for the treatment of malaria. 2007, WHO, Geneva
13.
World Health Organization: Technical Expert Group Meeting on Intermittent Preventive Treatment in Pregnancy (IPTp). 2008, WHO, Geneva
14.
Garner P, Gulmezoglu A: Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev. 2006, 18: CD000169-
15.
National Population Commission Nigeria: ICF Macro. 2008, DHS, Nigeria, Final Report (English) Calverton, MD: Macro International; 2009
16.
Briand V, Denoeud L, Massougbodji A, Cot M: Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin. J Infect Dis. 2008, 198: 594-601. 10.1086/590114.CrossRefPubMed
17.
Denoeud L, Fievet N, Aubouy A, Ayemonna P, Kiniffo R, Massougbodji A, Cot M: Is chloroquine chemoprophylaxis still effective to prevent low birth weight?. Results of a study in Benin. Malar J. 2007, 6: 27-10.1186/1475-2875-6-27.PubMed
18.
Le Port A, Cottrell G, Dechavanne C, Briand V, Bouraima A, Guerra J, Choudat I, Massougbodji A, Fayomi B, Migot-Nabias F, Garcia A, Cot M: Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin. Am J Trop Med Hyg. 2011, 84: 270-275. 10.4269/ajtmh.2011.10-0319.CrossRefPubMed
19.
Desai M, Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. The Lancet Infectious Diseases. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.CrossRefPubMed
20.
Murphy SC, Breman JG: Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. American Journal of triopical Medicine and Hygiene. 2001, 64: 57-67.
21.
Guyatt H, Snow R: Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2001, 95: 569-576. 10.1016/S0035-9203(01)90082-3.CrossRefPubMed
22.
Guyatt H, Snow R: Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004, 17: 760-769. 10.1128/CMR.17.4.760-769.2004.CrossRefPubMedPubMedCentral
23.
Idowu O, Mafiana C, Dapo S: Malaria among pregnant women in Abeokuta, Nigeria. Tanzania Health Research Bulletin. 2006, 8: 28-31.PubMed
24.
Lamina MA: Gestational age sat first antenatal attendance in Sagamu, western Nigeria. Nig J Clin Pract. 2004, 7 (1): 1-3.
25.
Sule-Odu AO: Maternal deaths in Sagamu, Nigeria. Int J Gynecol Obstet. 2000, 69: 47-9. 10.1016/S0020-7292(99)00199-X.CrossRef
26.
Turkur IU, Thatcher TD, Sagay SA, Madaki JKA: A comparison of sufadoxine-pyrimethamine with chloroquine and pyrimathaminefor prevention of malaria in pregnant Nigerian women. Am J Trop Med Hyg. 2007, 76 (6): 1019-1023.
27.
Anders K, Marchant T, Chambo P: Timing of intermittent preventive treatment for malaria during pregnancy and the implications of the current policy on early uptake in north-east Tanzania). Malar J. 2008, 7: 79-10.11186/1475-2875-7-79.CrossRefPubMedPubMedCentral
28.
Pagel C, Lewycka S, Colbourn T, Mwansambo C, Meguid T, Chiudzu G, Utley M, Costello AML: Estimation of potential eff ects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet. 2009, 1441-1448.
29.
Freeman P, Perry HB, Gupta SK, Rassekh B: Accelerating progress in achieving the millennium development goal for children through community-based approaches. Glob Public Health. 2009, 3: 1-20.
30.
Katabarwa MN, Habomugisha P, Richards FO, Hopkins D: Community-directed interventions strategy enhances efficient and effective integration of health care delivery and development activities in rural disadvantaged communities of Uganda. Trop Med Int Health. 2005, 10: 312-321. 10.1111/j.1365-3156.2005.01396.x.CrossRefPubMed
31.
Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW: Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors. 2009, 2: 39-10.1186/1756-3305-2-39.CrossRefPubMedPubMedCentral
32.
WHO: Unicef. Management of sick children by community health workers. Intervention models and programme examples. 2006, WHO, Geneva
33.
Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, Brabin BJ: Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health. 2009, 14: 183-189. 10.1111/j.1365-3156.2008.02197.x.CrossRefPubMed
34.
Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Martensson A: Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study. Malar J. 2011, 10: 64-10.1186/1475-2875-10-64.CrossRefPubMedPubMedCentral
35.
WHO/APOC: Revitalising health care delivery in sub-Saharan Africa. The potential of community-directed interventions to strengthen health systems. 2007, WHO, Geneva
36.
Onwujekwe O, Ojukwu J, Shu E, Uzochukwu B: Inequities in valuation of benefits, choice of drugs, and mode of payment for malaria reatment services provided by community health workers in Nigeria. Am J Trop Med Hyg. 2007, 77: 16-21.PubMed
37.
Katabarwa NM, MutabaziI D, Richards FO: Controlling onchocerciasis by community directed ivermectin treatment programmes (CDITP) in Uganda: why do some communities succeed and other fail?. Ann Trop Med Parasitol. 1999, 94: 343-352.
Metadata
Title
Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria
Authors
Olorunfemi E Amoran
Adebayo A Ariba
Christy A Iyaniwura
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Reproductive Health / Issue 1/2012
Electronic ISSN: 1742-4755
DOI
https://doi.org/10.1186/1742-4755-9-12

Other articles of this Issue 1/2012

Reproductive Health 1/2012 Go to the issue

Research

Do Malawian women critically assess the quality of care? A qualitative study on women’s perceptions of perinatal care at a district hospital in Malawi

Research

Swedish high school students' knowledge and attitudes regarding fertility and family building

Research

India's JSY cash transfer program for maternal health: Who participates and who doesn't - a report from Ujjain district

Research

Prevalence of institutional delivery and associated factors in Dodota Woreda (district), Oromia regional state, Ethiopia

Research

Parent-young people communication about sexual and reproductive health in E/Wollega zone, West Ethiopia: Implications for interventions

Research

Men’s knowledge and awareness of maternal, neonatal and child health care in rural Bangladesh: a comparative cross sectional study